| Literature DB >> 29165145 |
Rishila Ghosh1, Manushi Siddarth2, Neeru Singh1, Vipin Tyagi1, Pawan Kumar Kare1, Basu Dev Banerjee1, Om Prakash Kalra3, Ashok Kumar Tripathi4.
Abstract
BACKGROUND: Involvement of agrochemicals have been suggested in the development of chronic kidney disease of unknown etiology (CKDu). The association between CKDu and blood level of organochlorine pesticides (OCPs) in CKDu patients has been examined in the present study.Entities:
Keywords: Chronic kidney disease of unknown etiology; Organochlorine pesticides; Urinary albumin; eGFR
Mesh:
Substances:
Year: 2017 PMID: 29165145 PMCID: PMC5664840 DOI: 10.1186/s12199-017-0660-5
Source DB: PubMed Journal: Environ Health Prev Med ISSN: 1342-078X Impact factor: 3.674
Demographic features and biochemical parameters of the study subjects
| Characteristics | Healthy controls ( | CKDk patients ( | CKDu patients ( | One-way ANOVA | Significance |
|---|---|---|---|---|---|
| I | II | III | |||
| Age (years) | 42.76 ± 12.6 | 43.73 ± 11.3 | 45.23 ± 12.5 | 0.135 | |
| Sex (M/F) | 60:40 | 60:40 | 60:40 | ||
| BMI (kg/m2) | 22.06 ± 1.8 | 21.94 ± 3.2 | 21.46 ± 2.1 | 0.621 | |
| Blood pressure (mmHg) SBP | 119.07 ± 9.1 | 137.8 ± 15.2 | 128.8 ± 11.2 | 0.00* | I vs II = 0.000 |
| I vs III = 0.000 | |||||
| II vs III = 0.000 | |||||
| Blood pressure (mmHg) DBP | 75.37 ± 4.4 | 90.6 ± 9.5 | 74.47 ± 7.3 | 0.00* | I vs II = 0.000 |
| I vs III = 0.113 | |||||
| II vs III = 0.001 | |||||
| Fasting plasma glucose (mg/dL) | 91.83 ± 5.63 | 148.83 ± 5.23 | 92.10 ± 4.36 | 0.044* | I vs II = 0.000 |
| I vs III = 0.999 | |||||
| II vs III = 0.000 | |||||
| Post prandial plasma glucose (mg/dL) | 119.2 ± 4.26 | 197.43 ± 6.38 | 115 ± 3.25 | 0.029* | I vs II = 0.000 |
| I vs III = 0.903 | |||||
| II vs III = 0.000 | |||||
| Total cholesterol (mg/dL) | 160 ± 8.1 | 189.74 ± 16.5 | 190.9 ± 18.2 | 0.004* | I vs II = 0.000 |
| I vs III = 0.684 | |||||
| II vs III = 0.000 | |||||
| Triglyceride (mg/dL) | 86.3 ± 6.9 | 148.28 ± 11.7 | 129.97 ± 16.8 | 0.001* | I vs II = 0.023 |
| I vs III = 0.01 | |||||
| II vs III = 0.04 | |||||
| Total lipid (mg/dL) | 519.82 ± 25.6 | 600.52 ± 10.9 | 612.2 ± 11.5 | 0.005* | I vs II = 0.001 |
| I vs III = 0.01 | |||||
| II vs III = 0.04 | |||||
| Blood urea (mg/dL) | 20.8 ± 4.7 | 65.5 ± 18.0 | 70.8 ± 18.8 | 0.000* | I vs II = 0.000 |
| I vs III = 0.000 | |||||
| II vs III = 0.097 | |||||
| eGFR (mL/min/1.73 m2) | 99.2 ± 10.8 | 57.5 ± 9.4 | 59.3 ± 10.5 | 0.000* | I vs II = 0.004 |
| I vs III = 0.001 | |||||
| II vs III = 0.321 | |||||
| Urinary albumin excretion mg/dL (24 h), median (25–75th percentile)a | 26.0 (22.0–30.0) | 850.0 (377.5–1925.0) | 870.0 (350.0–1630.0) | 0.008* | I vs II = 0.000 |
All data represents the mean ± SD; one-way ANOVA with post hoc Tukey test was applied for significance test
*p value is significant at <0.05
aKruskal-Wallis test was applied for comparison of 24 h urinary albumin excretion data
Level of organochlorine pesticides in study subjects
| OCPs (ppb) | Group I healthy controls ( | Group II CKDk patients ( | Group III CKDu patients ( | Kruskal-Wallis test | Significance |
|---|---|---|---|---|---|
| Median (25th–75th percentile) | Median (25th–75th percentile) | Median (25th–75th percentile) | (Bonferroni adjusted | ||
| α-HCH | 0.7 (0.002–1.66) | 1.26 (0.34–3.15) | 1.68 (0.12–4.26) | 0.004* | I vs II = 0.02 |
| I vs III = 0.01 | |||||
| II vs III = 0.06 | |||||
| β-HCH | 1.7 (0.002–3.96) | 2.49 (0.84–4.65) | 2.15 (0.64–5.16) | 0.561 | I vs II = 0.265 |
| I vs III = 0.341 | |||||
| II vs III = 0.685 | |||||
| γ-HCH | 2.6 (0.002–3.21) | 2.15 (0.64–4.23) | 2.03 (0.002–2.49) | 0.236 | I vs II = 0.369 |
| I vs III = 0.215 | |||||
| II vs III = 0.347 | |||||
| Aldrin | 1.6 (0.002–2.15) | 1.96 (0.002–3.12) | 2.15 (0.002–3.18) | 0.045* | I vs II = 0.064 |
| I vs III = 0.045 | |||||
| II vs III = 0.896 | |||||
| Dieldrin | 2.5 (0.002–3.25) | 0.89 (0.002–2.01) | 1.95 (0.26–4.36) | 0.412 | I vs II = 0.452 |
| I vs III = 0.426 | |||||
| II vs III = 0.439 | |||||
| α-endosulfan | 0.7 (0.002–1.12) | 0.49 (0.002–1.32) | 2.18 (0.28–4.59) | 0.321 | I vs II = 0.365 |
| I vs III = 0.254 | |||||
| II vs III = 0.615 | |||||
| β-endosulfan | 1.3 (0.002–2.65) | 0.84 (0.002–1.54) | 2.38 (0.65–4.28) | 0.001* | I vs II = 0.055 |
| I vs III = 0.042 | |||||
| II vs III = 0.012 | |||||
|
| 1.2 (0.002–2.15) | 0.23 (0.002–0.23) | 2.36 (0.95–4.66) | 0.061 | I vs II = 0.321 |
| I vs III = 0.354 | |||||
| II vs III = 0.316 | |||||
|
| 2.6 (0.002–3.54) | 1.54 (0.29–2.64) | 2.94 (0.68–4.58) | 0.03* | I vs II = 0.01 |
| I vs III = 0.04 | |||||
| II vs III = 0.03 |
Kruskal-Wallis test was applied to compare the OCP data in different groups
*Significance level p < 0.05
Spearman’s correlation coefficient between OCP levels, eGFR, and urinary albumin excretion of CKD patients
| OCPs (ppb) | Correlation coefficient ( | Correlation coefficient ( | |
|---|---|---|---|
| α-HCH | eGFR | −0.11 | −0.152 |
| UAE | 0.103 | 0.132 | |
| β-HCH | eGFR | −0.145 | −0.162 |
| UAE | 0.163 | 0.156 | |
| γ-HCH | eGFR | −0.151* | −0.199* |
| UAE | 0.251* | 0.269* | |
| Aldrin | eGFR | −0.123 | −0.194* |
| UAE | 0.143 | 0.204* | |
| Dieldrin | eGFR | −0.111 | −0.129 |
| UAE | 0.159 | 0.164 | |
| α-endosulfan | eGFR | −0.132 | −0.163 |
| UAE | 0.152 | 0.145 | |
| β-endosulfan | eGFR | −0.174 | −0.201* |
| UAE | 0.158 | 0.216* | |
|
| eGFR | −0.162 | −0.123 |
| UAE | 0.172 | 0.168 | |
|
| eGFR | −0.222* | −0.284* |
| UAE | 0.259* | 0.256* |
eGFR estimated glomerular filtration, UAE 24-h urinary albumin excretion
*Significance level p < 0.05
Association of organochlorine pesticides with study subjects
| OCP (ppb) | 1st tertile | 2nd tertile | 3rd tertile | |
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
| α-HCH | Model 1 | Referent | 0.82 (0.63–1.25) | 0.99 (0.83–1.55) |
| Model 2 | 0.68 (0.54–1.49) | 1.72 (0.83–4.58) | ||
| Model 3 | 0.65 (0.43–1.48) | 1.95 (0.93–5.18) | ||
| β-HCH | Model 1 | Referent | 0.66 (0.48–1.12) | 1.72 (0.48–2.04) |
| Model 2 | 0.79 (0.62–1.67) | 1.66 (0.72–2.53) | ||
| Model 3 | 0.57 (0.45–1.69) | 1.29 (0.50–2.16) | ||
| γ-HCH | Model 1 | Referent | 0.52 (0.37–1.14) | 1.82 (0.83–3.58) |
| Model 2 | 0.78 (0.62–4.04) | 2.05 (1.84–4.04)* | ||
| Model 3 | 0.63 (0.37–1.0) | 0.93 (0.77–3.30) | ||
| Aldrin | Model 1 | Referent | 0.28 (0.16–1.24) | 1.61 (0.77–3.32) |
| Model 2 | 0.64 (0.45–1.64) | 1.05 (0.95–3.11) | ||
| Model 3 | 0.85 (0.89–1.27) | 1.15 (0.89–3.87) | ||
| Dieldrin | Model 1 | Referent | 0.48 (0.37–1.56) | 0.96 (0.57–1.56) |
| Model 2 | 0.84 (0.52–1.96) | 0.52 (0.32–1.87) | ||
| Model 3 | 0.94 (0.75–1.68) | 0.89 (0.58–2.53) | ||
| α-endosulfan | Model 1 | Referent | 0.39 (0.17–1.66) | 1.05 (0.92–3.53) |
| Model 2 | 0.92 (0.64–1.62) | 0.87 (0.38–2.49) | ||
| Model 3 | 0.88 (0.52–2.18) | 1.30 (0.63–2.67) | ||
| β-endosulfan | Model 1 | Referent | 0.58 (0.49–1.85) | 1.41 (0.68–2.87) |
| Model 2 | 0.48 (0.22–1.64) | 1.92 (1.15–3.00)* | ||
| Model 3 | 0.92 (0.85–2.67) | 2.16 (1.68–4.86)* | ||
|
| Model 1 | Referent | 0.64 (0.32–1.94) | 0.95 (0.32–2.93) |
| Model 2 | 0.64 (0.28–1.60) | 1.71 (0.68–3.90) | ||
| Model 3 | 1.56 (0.96–2.68) | 1.02 (0.59–2.50) | ||
|
| Model 1 | Referent | 0.49 (0.22–1.46) | 1.63 (1.10–2.93)* |
| Model 2 | 0.59 (0.52–1.64) | 2.13 (1.02–4.47)* | ||
| Model 3 | 1.87 (0.99–2.49) | 3.20 (1.48–6.94)* |
Model 1, association of blood level of OCPs with CKDk with reference to healthy controls; model 2, association of blood level of OCPs with CKDu with reference to healthy controls; model 3, association of blood level of OCPs with CKDu with reference to CKDk. Odds ratio were adjusted for age, sex, BMI, and total lipid content
OR odds ratio
*Significance p < 0.05